Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s00259-014-2833-4
Published Online: 2014-07-03
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Caicedo, Carlos
Garcia-Velloso, Maria Jose
Lozano, Maria Dolores
Labiano, Tania
Vigil Diaz, Carmen
Lopez-Picazo, Jose Maria
Gurpide, Alfonso
Zulueta, Javier
Richter Echevarria, Jose Angel
Perez Gracia, Jose Luis
Text and Data Mining valid from 2014-07-03